Ex vivo trypanocidal activity of 1-(2-hydroxybenzylidene)thiosemicarbazide against Trypanosoma equiperdum.

The research primarily focuses on assessing the effect of thiosemicarbazone derivatives on the Trypanosoma equiperdum parasite, which leads to a venereal disease in horses and donkeys. Notably, one particular compound outperformed the current drug treatment in inhibiting the parasite’s activity.

Introduction and Objectives

• The study’s key aim involves the evaluation of various thiosemicarbazone derivatives for their trypanocidal effectiveness against Trypanosoma equiperdum.
• Trypanosoma equiperdum is a parasite known to cause dourine, a venereal disease that affects horses and donkeys primarily.
• The parasite is ubiquitous, found in regions spanning Africa, Asia, Russia, Mexico, Venezuela, and parts of Europe.
• Despite its morphological similarities with other Trypanozoon species, T. equiperdum distinguishes itself by being primarily a tissue parasite leading to skin plaques, genital swelling, and neurological symptoms.

Methodology

• The research was conducted through an ex vivo culture involving T. equiperdum.
• A series of thiosemicarbazone derivatives were applied to the cultured parasites to gauge their trypanocidal effectiveness.

Findings

• All tested compounds demonstrated trypanocidal activity against T. equiperdum to certain degrees. However, one compound displayed superior solubility and a dose-dependent effect, rendering it the most effective.
• With a median inhibitory concentration (IC) of 1.2μM, the identified compound outperformed diminazene aceturate, a standard treatment for animal trypanosomiasis, in terms of inhibitory activity.

Implications and Conclusion

• The superior performance of the newly identified compound suggests that it may offer a valuable alternative to the traditional drug treatment against venereal disease caused by T. equiperdum in horses and donkeys.
• This research highlights the potential of thiosemicarbazone derivatives in the development of more effective treatments for trypanosomiasis in animals.
• Further studies must be conducted in vivo to confirm the safety and efficacy of the compound before it can be recommended for practical use.